Top Ranked Healthcare Companies by Fundamental Value
Demographic tailwinds are well-known. What the market often misprices is the fundamental quality of the businesses riding them. Pharma, biotech, medtech and health services — identify undervalued healthcare stocks ranked by fundamental quality. This is a delayed sample snapshot (last refreshed 2026-03-16), not the live dashboard feed.
Top-Ranked Healthcare Stocks 2026
Ranked by total fundamental score from a delayed sample snapshot. Top 3 rows show visible values — create a free account to unlock the full live list in Dashboard.
| Ticker | Company | Country | Rating | Value Score | Quality Score | Discount |
|---|---|---|---|---|---|---|
| BAVA.CO | Bavarian Nordic A/S | Denmark | BUY | 89 | 69 | 0.2% |
| GMAB | Genmab A/S | Denmark | WATCH | 80 | 71 | 0.2% |
| RMD.AX | ResMed Inc. | United States | BUY | 75 | 74 | 0.3% |
| HLUN-B.CO | H. Lundbeck A/S | Denmark | BUY | |||
| CRMD | CorMedix Inc. | United States | BUY | |||
| ACAD | ACADIA Pharmaceuticals Inc. | United States | BUY | |||
| SAN.PA | Sanofi | France | BUY | |||
| ZTS | Zoetis Inc. | United States | BUY | |||
| TTALO.HE | Terveystalo Oyj | Finland | BUY | |||
| HAE | Haemonetics Corporation | United States | BUY | |||
| A | Agilent Technologies, Inc. | United States | BUY | |||
| DXCM | DexCom, Inc. | United States | BUY | |||
| CHE | Chemed Corporation | United States | BUY | |||
| NOVO-B.CO | Novo Nordisk A/S | Denmark | BUY | |||
| MDXG | MiMedx Group, Inc. | United States | BUY | |||
| COLO-B.CO | Coloplast A/S | Denmark | BUY | |||
| GILD | Gilead Sciences, Inc. | United States | BUY | |||
| DOCS | Doximity, Inc. | United States | BUY | |||
| HQY | HealthEquity, Inc. | United States | BUY | |||
| INSP | Inspire Medical Systems, Inc. | United States | BUY |
Create a free account to unlock full live scores in Dashboard.
Why Healthcare Value Stocks?
Healthcare businesses often produce stable, recurring revenue insulated from economic cycles. Patent cliffs, regulatory approvals, and pipeline events can temporarily depress prices well below long-term intrinsic value. Value investors who understand these dynamics can accumulate quality healthcare names at meaningful discounts. Stedrok applies a quantitative lens to separate temporarily depressed quality companies from genuinely impaired businesses.
Read more: How Stedrok scores stocks · Value investing glossary · Our investment philosophy
Frequently Asked Questions
What defines an undervalued healthcare stock?
An undervalued healthcare stock trades below Stedrok's estimated intrinsic value — derived from normalised free cash flow, return on invested capital, and sector-adjusted multiples. A high discount percentage combined with a strong quality score signals the most attractive setups.
How does Stedrok evaluate biotech companies?
Biotech companies with no revenue are excluded from Stedrok's primary screens. For revenue-generating healthcare firms, Stedrok weighs pipeline optionality against current earnings power and balance sheet strength, applying conservative FCF-based valuations.
Is healthcare a defensive sector for value investing?
Yes — healthcare has historically shown lower earnings volatility during recessions. Stedrok's sector scores reflect this by calibrating risk thresholds to healthcare-specific metrics such as R&D capitalisation, regulatory pipeline, and pricing power.
Explore Other Sectors
Stedrok covers 8 sectors. Browse AI-screened value picks across the full market universe.
See All Rated Healthcare Stocks
Stedrok scores every rated Healthcare company daily. Subscribe to unlock full scores, estimated values, and real-time watchlists.